Cargando…
FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity
FOXA2 encodes a transcription factor mutated in 10% of endometrial cancers (ECs), with a higher mutation rate in aggressive variants. FOXA2 has essential roles in embryonic and uterine development. However, FOXA2’s role in EC is incompletely understood. Functional investigations using human and mous...
Autores principales: | Sahoo, Subhransu S., Ramanand, Susmita G., Gao, Yunpeng, Abbas, Ahmed, Kumar, Ashwani, Cuevas, Ileana C., Li, Hao-Dong, Aguilar, Mitzi, Xing, Chao, Mani, Ram S., Castrillon, Diego H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197528/ https://www.ncbi.nlm.nih.gov/pubmed/35703180 http://dx.doi.org/10.1172/JCI157574 |
Ejemplares similares
-
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
por: Cuevas, Ileana C., et al.
Publicado: (2019) -
Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
por: Sahoo, Subhransu S., et al.
Publicado: (2022) -
Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry
por: Aguilar, Mitzi, et al.
Publicado: (2022) -
Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors
por: Aguilar, Mitzi, et al.
Publicado: (2021) -
β-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions
por: Aguilar, Mitzi, et al.
Publicado: (2023)